VITAFOL-OB + DHA Rx
Generic Name and Formulations:
Vit.A (as beta carotene) 2700 IU, thiamine 1.6mg, riboflavin 1.8mg, niacinamide 18mg, pyridoxine 2.5mg, folic acid 1mg, Vit.B12 12mcg, Vit.C 70mg, Vit.D 400 IU, Vit.E 30 IU, calcium (as carbonate) 100mg, copper (as oxide) 2mg, iron (as ferrous fumarate) 65mg, magnesium (as oxide) 25mg, zinc (as oxide) 25mg; caplets; gluten-, lactose-, iodine-, sugar-free. Docosahexaenoic acid (DHA) 250mg; gel caps; orange flavor.
Indications for VITAFOL-OB + DHA:
Nutritional supplement in pregnancy, prenatal, and postnatal periods.
1 caplet + 1 gel cap daily.
Pernicious anemia. Hemochromatosis. Iron storage disease. Chronic hemolytic anemia. Pyridoxine responsive anemia. Liver cirrhosis.
Folic acid may mask pernicious anemia. Overactive thyroid. Hypercalcemia. Hyperparathyroidism. Soy allergy. DHA: bleeding diatheses.
Iron, calcium block tetracycline absorption. Iodine with anti-thyroid drugs may cause hypothyroidism. Iodine with antihypertensives may increase potassium. Folic acid antagonizes methotrexate, anticonvulsants (eg, carbamazepine, fosphenytoin, phenytoin, phenobarbital, valproic acid). Separate dosing of zinc with antibiotics at least 2hrs apart. DHA: avoid anticoagulants.
GI upset, skin ailments, glucose abnormalities, visual problems.
Caplets—100; Softgel caps—30;
DHA (6 blister cards [5 caplets + 5 gel caps])—30-day supply
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|